CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Expedeon AG Company Snapshot
Expedeon AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Expedeon AG with three other companies in this sector in Germany: 4Sc AG (2017 sales of 4.20 million Euro [US$4.90 million] ), Heidelberg Pharma Ag (1.90 million Euro [US$2.22 million] ), and MediGene AG (10.30 million Euro [US$12.01 million] of which 47% was Immunotherapies).

Sales Analysis. Sales increased substantially in 2017: Expedeon AG reported sales of 7.80 million Euro (US$9.10 million) for the year ending December of 2017. This represents an increase of 335.8% versus 2016, when the company's sales were 1.79 million Euro. This was the third consecutive year of growth at Expedeon AG.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Expedeon AG
  Stock Performance Chart for Expedeon AG
 
  Stock Data: Recent Stock Performance:
  Current Price (9/19/2018): 1.11
(Figures in Euro)
1 Week -17.3%   13 Weeks -19.9%  
4 Weeks -21.0%   52 Weeks -33.7%  
 
Expedeon AG Key Data:
  Ticker: EXN Country: Germany
  Exchanges: DUS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 7,797,000
(Year Ending Jan 2018).
Employees: 89
  Currency: Euro Market Cap: 56,129,363
  Fiscal Yr Ends: December Shares Outstanding: 50,658,270
  Share Type: Stammaktie Closely Held Shares: 8,748,390
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.